CMV: a warrior against leukemia?

نویسنده

  • Per Ljungman
چکیده

In this issue of Blood, Green et al provide additional information supporting that cytomegalovirus (CMV) reduces leukemia relapse after allogeneic stem cell transplantation.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Pluronic based nano-delivery systems; Prospective warrior in war against cancer

Pluronic based nano-particulate systems are innovative platforms for delivery of anti-cancer agents. These systems due to their pharmacological properties and suitable physicochemical characteristics are great opportunity for development cancer therapeutics. This mini-review tries to provide a more detailed overview on the currently available pluronic based drug delivery systems. In the section...

متن کامل

CMV-colitis in a pediatric non-transplant ALL patient receiving chemotherapy; A case report

Cytomegalovirus (CMV) is the leading cause of viral-associated congenital infections. Moreover, it can also be acquired. Between 50 to 80 percent of the world’s population is seropositive for CMV and most clinical disease occurs in individuals previously infected with CMV. Rarely, serious CMV infection has occurred in individuals with healthy immune system. In contrast to immunocompetent patien...

متن کامل

سطح بالای پاسخ ایمنی اختصاصی لنفوسیت‌های CD4+وCD8+ نسبت به سیتومگالوویروس و همبستگی بین آن‌ها در بیماران مبتلا به لوسمی لنفوسیتی مزمن سلولB

  High level of CMV-specific CD4+ and CD8+cells Immune Response and Correlation Between them in B-cell Chronic Lymphocytic Leukemia Patients     B. Pourgheysri [1] , P. Moss [2]     Received: 10/09/07 Sent for Revision: 05/03/08 Received Revised Manuscript: 06/12/08 Accepted: 30/12/08   Background and Objective: Chronic lymphocytic leukemia (CLL) is characterized by a monoclonal proliferation o...

متن کامل

The silent war against CMV in CLL.

In this issue of Blood, Pourgheysari and colleagues demonstrate that there is a highly exaggerated expansion of CMV-specific CD4 T cells in CMV-seropositive compared with CMV-seronegative CLL patients, particularly after chemotherapy.1 Despite this, patient survival is reduced by almost 4 years in the CMV cohort. However, as CMV CLL individuals do not exhibit symptoms of CMV-induced disease, th...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Blood

دوره 122 7  شماره 

صفحات  -

تاریخ انتشار 2013